Active surveillance for prostate cancer: a narrative review of clinical guidelines

@article{Bruinsma2016ActiveSF,
  title={Active surveillance for prostate cancer: a narrative review of clinical guidelines},
  author={Sophie M Bruinsma and Chris H. Bangma and Peter R. Carroll and Michael S. Leapman and A S Sakari Rannikko and Neophytos Petrides and Mahesha Weerakoon and Leonard P Bokhorst and Monique J Roobol},
  journal={Nature Reviews Urology},
  year={2016},
  volume={13},
  pages={151-167}
}
In the past decade active surveillance (AS) of men with localized prostate cancer has become an increasingly popular management option, and a range of clinical guidelines have been published on this topic. Existing guidelines regarding AS for prostate cancer vary widely, but predominantly state that the most suitable patients for AS are those with pretreatment clinical stage T1c or T2 tumours, serum PSA levels <10 ng/ml, biopsy Gleason scores of 6 or less, a maximum of one or two tumour… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 14 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Active Surveillance for Localized Prostate Cancer

Current Clinical Urology • 2018
View 9 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Long‐term follow‐up of a large active surveillance cohort of patients with prostate cancer

L Klotz
J. Clin. Oncol • 2015

Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review

Schoots, G I.
Eur. Urol • 2015

Similar Papers

Loading similar papers…